Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 3055 | 210 | 0.7398 | 0.6962 | 0.0687 | 0.0731 |
WM-115 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2606 | 184 | 0.6298 | 0.6962 | 0.0706 | 0.0731 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 3407 | 205 | 0.8326 | 0.8606 | 0.0602 | 0.0629 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 3631 | 226 | 0.8854 | 0.8606 | 0.0622 | 0.0629 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3558 | 236 | 0.8638 | 0.8606 | 0.0663 | 0.0629 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2904 | 195 | 0.7044 | 0.7665 | 0.0671 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3246 | 205 | 0.7908 | 0.7665 | 0.0632 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3316 | 223 | 0.8043 | 0.7665 | 0.0672 | 0.0659 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2757 | 194 | 0.6665 | 0.6617 | 0.0704 | 0.0684 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 2651 | 173 | 0.6444 | 0.6617 | 0.0653 | 0.0684 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 2787 | 194 | 0.6743 | 0.6617 | 0.0696 | 0.0684 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2506 | 243 | 0.5885 | 0.5553 | 0.0970 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2322 | 246 | 0.5398 | 0.5553 | 0.1059 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2278 | 211 | 0.5375 | 0.5553 | 0.0926 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 3037 | 214 | 0.7341 | 0.7069 | 0.0705 | 0.0799 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 2971 | 248 | 0.7081 | 0.7069 | 0.0835 | 0.0799 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2855 | 245 | 0.6787 | 0.7069 | 0.0858 | 0.0799 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 2669 | 252 | 0.6285 | 0.6528 | 0.0944 | 0.0956 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 2791 | 271 | 0.6553 | 0.6528 | 0.0971 | 0.0956 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 2867 | 273 | 0.6745 | 0.6528 | 0.0952 | 0.0956 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2214 | 217 | 0.5193 | 0.4954 | 0.0980 | 0.0888 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 2106 | 168 | 0.5039 | 0.4954 | 0.0798 | 0.0888 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1953 | 173 | 0.4629 | 0.4954 | 0.0886 | 0.0888 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 2173 | 305 | 0.4857 | 0.4743 | 0.1404 | 0.1338 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 2061 | 274 | 0.4647 | 0.4743 | 0.1329 | 0.1338 |